⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for Study of Bendamustine Hydrochloride for the Treatment of Pediatric Patients With Relapsed or Refractory Acute Leukemia

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: Study of Bendamustine Hydrochloride for the Treatment of Pediatric Patients With Relapsed or Refractory Acute Leukemia

Official Title: An Open-Label Study of Bendamustine Hydrochloride for the Treatment of Pediatric Patients With Relapsed or Refractory Acute Leukemia

Study ID: NCT01088984

Conditions

Leukemia

Interventions

Bendamustine

Study Description

Brief Summary: The primary objective of phase 1 of this study is to establish the recommended phase II dose (RP2D). The primary objective of phase 2 of this study is to evaluate the safety and efficacy of bendamustine at the recommended pediatric dose for the treatment of pediatric patients with relapsed or refractory acute leukemia.

Detailed Description:

Keywords

Eligibility

Minimum Age: 1 Year

Eligible Ages: CHILD, ADULT

Sex: ALL

Healthy Volunteers: No

Locations

Teva Investigational Site 17, Orange, California, United States

Teva Investigational Site 12, San Diego, California, United States

Teva Investigational Site 10, St. Petersburg, Florida, United States

Teva Investigational Site 8, Baltimore, Maryland, United States

Teva Investigational Site 16, Boston, Massachusetts, United States

Teva Investigational Site 9, Detroit, Michigan, United States

Teva Investigational Site 1, Jackson, Mississippi, United States

Teva Investigational Site 5, Kansas City, Missouri, United States

Teva Investigational Site 14, St. Louis, Missouri, United States

Teva Investigational Site 15, New York, New York, United States

Teva Investigational Site 18, Portland, Oregon, United States

Teva Investigational Site 11, Hershey, Pennsylvania, United States

Teva Investigational Site 7, Philadelphia, Pennsylvania, United States

Teva Investigational Site 19, Memphis, Tennessee, United States

Teva Investigational Site 3, Dallas, Texas, United States

Teva Investigational Site 4, Fort Worth, Texas, United States

Teva Investigational Site 13, Houston, Texas, United States

Teva Investigational Site 2, Seattle, Washington, United States

Teva Investigational Site 6, Milwaukee, Wisconsin, United States

Teva Investigational Site 300, Herston, , Australia

Teva Investigational Site 301, Parkville, , Australia

Teva Investigational Site 302, Randwick, , Australia

Teva Investigational Site 520, Minsk, , Belarus

Teva Investigational Site 615, Barretos-SP, , Brazil

Teva Investigational Site 616, Caxias do Sul, , Brazil

Teva Investigational Site 613, Curitiba-PR, , Brazil

Teva Investigational Site 612, Porto Alegre, , Brazil

Teva Investigational Site 614, Porto Alegre, , Brazil

Teva Investigational Site 617, Sao Paulo-SP, , Brazil

Teva Investigational Site 610, Sao Paulo, , Brazil

Teva Investigational Site 611, Sao Paulo, , Brazil

Teva Investigational Site 100, Toronto, , Canada

Teva Investigational Site 501, Jerusalem, , Israel

Teva Investigational Site 503, Petach Tikva, , Israel

Teva Investigational Site 502, Ramat Gan, , Israel

Teva Investigational Site 330, Seoul, , Korea, Republic of

Teva Investigational Site 331, Seoul, , Korea, Republic of

Teva Investigational Site 332, Seoul, , Korea, Republic of

Teva Investigational Site 333, Seoul, , Korea, Republic of

Teva Investigational Site 603, Guadalajara, , Mexico

Teva Investigational Site 600, Mexico City, , Mexico

Teva Investigational Site 601, Mexico City, , Mexico

Teva Investigational Site 602, Monterrey, , Mexico

Teva Investigational Site 303, Auckland, , New Zealand

Teva Investigational Site 531, Bialystok, , Poland

Teva Investigational Site 530, Lublin, , Poland

Teva Investigational Site 532, Warszawa, , Poland

Teva Investigational Site 511, Moscow, , Russian Federation

Teva Investigational Site 510, St. Petersburg, , Russian Federation

Teva Investigational Site 320, Singapore, , Singapore

Contact Details

Name: Sponsor's Medical Expert

Affiliation: Cephalon

Role: STUDY_DIRECTOR

Useful links and downloads for this trial

Clinicaltrials.gov

Google Search Results

Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: